We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Calls for Details, Narratives in Marketing Applications
EMA Calls for Details, Narratives in Marketing Applications
Drugmakers need to provide adequate details — and include narratives — in describing manufacturing processes in their applications, but can leave out elements such as machinery serial numbers and general GMPs, according to the European Medicines Agency.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor